

Peer Reviewed publications
1. Ojemolon, P. E., Kwei-Nsoro, R., Haque, M., Shah, M. P., Pinnam, B., & Almoghrabi, A. (2023). Different Approaches to the Management of Cholecystoenteric Fistula. ACG Case Reports Journal, 10(1), e00960.
2. Park, D.Y., An S., Rodriguez, M.A., Odeh, R., Hammo, H., Haque, Mahaim., Abdul, A. W. (2022). Impact of End Stage Renal Disease on in-hospital outcomes of hypertensive emergency from the national inpatient sample, 2016-2018. Pubmed Index. PMID: 36304605
3. Sakibuzzaman,M., Fariza,T.T., Rahman,S.M.T., Haque,M.M. & Moosa,S.A.. A Clinical Review of COVID-19 Associated Myocarditis. Archives of Clinical and Biomedical Research. 2020, Oct; 4(5): 468-480. Pub Status: Published.
Manuscripts under review:
1. Ojemolon, P. E., Kwei-Nsoro, R., Haque, M., Kanemo, P., Shaka, H., & Attar, B. (2023). The Effect of the COVID-19 Pandemic on Epidemiological Trends and Outcomes of Hospitalizations for Cholecystitis and Symptomatic Cholelithiasis. Baylor University Medical Center Proceedings; In-review.
Abstracts
1. Ojemolon, P., Akuna, E., Leonard, A., Shekar, N., Haque, M., Huang, Y., & Williams, D. (2022). Impact of end-stage renal disease and chronic kidney disease stages III-V on outcomes of hospitalizations for upper gastrointestinal bleeding (from the National Inpatient Sample 2016-2017). American Journal of Kidney Diseases, 79(4), S100–S101.
2. Shekar, N., Akuna, E., Haque, M., Huang, Y., Leonard, A., Ojemolon, P., & Williams, D. (2022). Outcomes of patients with CKD III-V vs ESRD admitted for hypertensive emergency (from the National Inpatient Sample 2016-2017). American Journal of Kidney Diseases, 79(4), S96–S96.
3. Williams, D., Asemota, I., Huang, Y., Murthi, M., Haque, M., Ojemolon, P., Shekar, N., & Leonard, A. (2022). Impact of ACS on adult patients admitted with coexisting CKD stages III-V vs. ESRD (from the National Inpatient Sample 2016-2017). American Journal of Kidney Diseases, 79(4), S77–S78.